Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Agenus Inc. (NASDAQ : AGEN ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others.
Quote
| Last: | $4.13 |
|---|---|
| Change Percent: | 5.49% |
| Open: | $3.91 |
| Close: | $3.915 |
| High: | $4.303 |
| Low: | $3.9 |
| Volume: | 708,606 |
| Last Trade Date Time: | 04/13/2026 12:45:04 pm |
Stock Data
| Market Cap: | $105,425,882 |
|---|---|
| Float: | 32,137,890 |
| Insiders Ownership: | 0.93% |
| Institutions: | 42 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.agenusbio.com |
| Country: | US |
| City: | Lexington |
Recent News Releases
Subscribe to Our Newsletter
Message Board Posts
investorshub : US Market News
investorshub : US Market News
investorshub : US Market News
investorshub : US Market News
**MWN-AI FAQ is based on asking OpenAI questions about Agenus Inc. (NASDAQ: AGEN).
